Duloxetine HCl
| Nom du produit | Duloxetine HCl |
|---|---|
| Numéro CAS | 136434-34-9 |
| Formule moléculaire | C18H19NOS·HCl |
| Poids moléculaire | 333.88 g/mol |
| Apparence | Poudre cristalline blanche à blanc cassé |
| Essai (HPLC) | 98.0% – 102.0% (on dried basis) |
| Perte au séchage | ≤ 0,5% |
| Résidu au feu | ≤ 0,11 TP3T |
| Métaux lourds | ≤ 20 ppm |
| Colis | 25 kg fiber drum with double polyethylene bags |
Besoin d'aide ? Contacter notre équipe

Synonymes : (S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride, LY248686, Duloxetine hydrochloride, Cymbalta, Yentreve, Ariclaim, Xeristar
Duloxetine HCl is a dual serotonin and norepinephrine reuptake inhibitor (SNRI) that has become a cornerstone in the treatment of major depressive disorder, generalized anxiety disorder, and neuropathic pain. As a hydrochloride salt, it offers improved aqueous solubility and stability compared to the free base, making it the preferred form for oral solid dosage formulations. The compound was originally developed by Eli Lilly and received FDA approval in 2004 under the brand name Cymbalta.
Chemically, duloxetine HCl is a naphthalenyloxy-substituted thiophene propanamine. Its structure features a chiral center, and the active pharmaceutical ingredient is the (S)-enantiomer, which is significantly more potent than the (R)-enantiomer. The molecule’s lipophilic naphthalene and thiophene rings facilitate blood-brain barrier penetration, while the secondary amine side chain is responsible for its interaction with serotonin and norepinephrine transporters. This dual mechanism distinguishes it from selective serotonin reuptake inhibitors (SSRIs) and contributes to its broader efficacy profile.
From a manufacturing perspective, duloxetine HCl is synthesized through a multi-step process that typically starts from 1-naphthol and 2-acetylthiophene, followed by a resolution step to isolate the desired (S)-enantiomer. The final hydrochloride salt is crystallized to high purity, with particle size distribution carefully controlled to ensure consistent dissolution and bioavailability in finished dosage forms. Our material is produced under cGMP conditions and is supported by a comprehensive regulatory package, including DMF and CEP where applicable.
| Paramètre | Spécifications |
|---|---|
| Essai (HPLC) | 98.0% – 102.0% |
| Identification | IR and HPLC retention time match reference standard |
| Perte au séchage | ≤ 0,5% |
| Résidu au feu | ≤ 0,11 TP3T |
| Métaux lourds | ≤ 20 ppm |
| Limites microbiologiques | Nombre total de bactéries aérobies ≤ 1 000 UFC/g ; levures et moisissures ≤ 100 UFC/g ; absence d'E. coli |
Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China